Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 10/2003

01-10-2003 | Article

Type VIII adenylyl cyclase in rat beta cells: coincidence signal detector/generator for glucose and GLP-1

Authors: D. Delmeire, D. Flamez, S. A. Hinke, J. J. Cali, D. Pipeleers, F. Schuit

Published in: Diabetologia | Issue 10/2003

Login to get access

Abstract

Aims/hypothesis

The secretory function of pancreatic beta cells is synergistically stimulated by two signalling pathways which mediate the effects of nutrients and hormones such as glucagon-like peptide 1 (GLP-1), glucose-dependent insulinotropic peptide (GIP) or glucagon. These hormones are known to activate adenylyl cyclase in beta cells. We examined the type of adenylyl cyclase that is associated with this synergistic interaction.

Methods

Insulin release, cAMP production, adenylyl cyclase activity, mRNA and protein expression were measured in fluorescence-activated cell sorter-purified rat beta cells and in the rat beta-cell lines RINm5F, INS-1 832/13 and INS-1 832/2.

Results

In primary beta cells, glucagon and GLP-1 synergistically potentiate the stimulatory effect of 20 mmol/l glucose on insulin release and cAMP production. Both effects are abrogated in the presence of the L-type Ca2+-channel blocker verapamil. The cAMP-producing activity of adenylyl cyclase in membranes from RINm5F cells is synergistically increased by Ca2+-calmodulin and recombinant GTPγS-activated Gsα-protein subunits. This type of regulation is characteristic for type I and type VIII AC isoforms. Consistent with this functional data, AC mRNA analysis shows abundant expression of type VI AC, four splice variants of type VIII AC and low expression level of type I AC in beta cells. Type VIII AC expression at the protein level was observed using immunoblots of RINm5F cell extracts.

Conclusion/interpretation

This study identifies type VIII AC in insulin-secreting cells as one of the potential molecular targets for synergism between GLP-1 receptor mediated and glucose-mediated signalling.
Literature
1.
Pipeleers D (1987) The biosociology of pancreatic B cells. Diabetologia 30:277–291PubMed
2.
Pipeleers DG, Schuit FC, In't Veld PA et al. (1985) Interplay of nutrients and hormones in the regulation of insulin release. Endocrinology 117:824–833PubMed
3.
Huypens P, Ling Z, Pipeleers D, Schuit F (2000) Glucagon receptors on human islet cells contribute to glucose competence of insulin release. Diabetologia 43:1012–1019CrossRefPubMed
4.
Schuit FC, Pipeleers DG (1986) Differences in adrenergic recognition by pancreatic A and B cells. Science 232:875–877PubMed
5.
Mojsov S, Weir GC, Habener JF (1987) Insulinotropin: glucagon-like peptide I (7–37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J Clin Invest 79:616–619PubMed
6.
Newgard CB, McGarry JD (1995) Metabolic coupling factors in pancreatic beta-cell signal transduction. Annu Rev Biochem 64:689–719CrossRefPubMed
7.
Maechler P, Wollheim CB (2001) Mitochondrial function in normal and diabetic beta-cells. Nature 414:807–812PubMed
8.
Hellman B, Gylfe E, Bergsten P et al. (1994) Glucose induces oscillatory Ca2+ signalling and insulin release in human pancreatic beta cells. Diabetologia 37:S11–S20PubMed
9.
Henquin JC (2000) Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 49:1751–1760PubMed
10.
Prentki M, Tornheim K, Corkey BE (1997) Signal transduction mechanisms in nutrient-induced insulin secretion. Diabetologia 40:S32–S41CrossRefPubMed
11.
Flamez D, Berger V, Kruhoffer M, Orntoft T, Pipeleers D, Schuit FC (2002) Critical role for cataplerosis via citrate in glucose-regulated insulin release. Diabetes 51:2018–2024PubMed
12.
Henquin JC, Meissner HP (1984) The ionic, electrical, and secretory effects of endogenous cyclic adenosine monophosphate in mouse pancreatic B cells: studies with forskolin. Endocrinology 115:1125–1134PubMed
13.
Schuit FC, Pipeleers DG (1985) Regulation of adenosine 3′,5′-monophosphate levels in the pancreatic B cell. Endocrinology 117:834–840PubMed
14.
Lester LB, Langeberg LK, Scott JD (1997) Anchoring of protein kinase A facilitates hormone-mediated insulin secretion. Proc Natl Acad Sci USA 94:14942–14947CrossRefPubMed
15.
Ämmälä C, Eliasson L, Bokvist K et al. (1994) Activation of protein kinases and inhibition of protein phosphatases play a central role in the regulation of exocytosis in mouse pancreatic β cells. Proc Natl Acad Sci USA 91:4343–4347PubMed
16.
Lester LB, Faux MC, Nauert JB, Scott JD (2001) Targeted protein kinase A and PP-2B regulate insulin secretion through reversible phosphorylation. Endocrinology 142:1218–1227PubMed
17.
Ozaki N, Shibasaki T, Kashima Y et al. (2000) cAMP-GEFII is a direct target of cAMP in regulated exocytosis. Nat Cell Biol 2:805–811CrossRefPubMed
18.
Kashima Y, Miki T, Shibasaki T et al. (2001) Critical role of cAMP-GEFII-Rim2 complex in incretin-potentiated insulin secretion. J Biol Chem 276:46046–46053CrossRefPubMed
19.
Moens K, Heimberg H, Flamez D et al. (1996) Expression and functional activity of glucagon, glucagon-like peptide I, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells. Diabetes 45:257–261PubMed
20.
Scrocchi LA, Brown TJ, MaClusky N et al. (1996) Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat Med 2:1254–1258PubMed
21.
Miyawaki K, Yamada Y, Yano H et al. (1999) Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice. Proc Natl Acad Sci USA 96:14843–14847PubMed
22.
Flamez D, Van Breusegem A, Scrocchi LA et al. (1998) Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene. Diabetes 47:646–652PubMed
23.
Moens K, Flamez D, Van Schravendijk C, Ling Z, Pipeleers D, Schuit F (1998) Dual recognition by pancreatic β-cells via glucagon and glucagon-like peptide 1 receptors. Diabetes 47:66–72PubMed
24.
Scheen AJ, Castillo MJ, Lefebvre PJ (1996) Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: methodological aspects and clinical applications. Diabetes Metab 22:397–406PubMed
25.
Moens K, Berger V, Ahn JM et al. (2002) Assessment of the role of interstitial glucagon in the acute glucose secretory responsiveness of in situ pancreatic beta-cells. Diabetes 51:669–675PubMed
26.
Lawrence MC, Bhatt HS, Watterson JM, Easom RA (2001) Regulation of insulin gene transcription by a Ca(2+)-responsive pathway involving calcineurin and nuclear factor of activated T cells. Mol Endocrinol 15:1758–1767
27.
Lawrence MC, Bhatt HS, Easom RA (2002) NFAT regulates insulin gene promoter activity in response to synergistic pathways induced by glucose and glucagon-like peptide-1. Diabetes 51:691–698PubMed
28.
Pipeleers DG, In 't Veld PA, Van De Winkel M, Maes E, Schuit F, Gepts W (1985) A new in vitro method for the study of pancreatic A and B cells. Endocrinology 117:806–816PubMed
29.
Hohmeier HE, Mulder H, Chen G, Henkel-Rieger R, Prentki M, Newgard CB (2000) Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and-independent glucose-stimulated insulin secretion. Diabetes 49:424–430PubMed
30.
Cali JJ, Zwaagstra JC, Mons N, Cooper DMF, Krupinski J (1994) Type VIII adenylyl cyclase. A Ca2+/calmodulin-stimulated enzyme expressed in discrete regions of rat brain. J Biol Chem 269:12190–12195PubMed
31.
Krupinski J, Coussen F, Bakalyar HA et al. (1989) Adenylyl cyclase amino acid sequence: possible channel- or transporter-like structure. Science 244:1558–1564PubMed
32.
Cali JJ, Parekh RS, Krupinski J (1996) Splice variants of type VIII adenylyl cyclase: differences in glycosylation and regulation by Ca2+/calmodulin. J Biol Chem 271:1089–1095CrossRefPubMed
33.
Devis G, Somers G, Van Obberghen E, Malaisse WJ (1975) Calcium antagonists and islet function. I. Inhibition of insulin release by verapamil. Diabetes 24:247–251PubMed
34.
Lebrun P, Malaisse WJ, Herchuelz A (1982) Evidence for two distinct modalities of Ca2+ influx into pancreatic B cell. Am J Physiol 242:E59–E66PubMed
35.
Garcia M-C, Hermans MP, Henquin J-C (1988) Glucose-, calcium- and concentration-dependence of acetylcholine stimulation of insulin release and ionic fluxes in mouse islets. Biochem J 254:211–218PubMed
36.
Xia Z, Storm DR (1997) Calmodulin-regulated adenylyl cyclases and neuromodulation. Curr Opin Cell Biol 7:391–396CrossRef
37.
Cooper DM, Karpen JW, Fagan KA, Mons NE (1998) Ca(2+)-sensitive adenylyl cyclases. Adv Second Messenger Phosphoprotein Res 32:23–51PubMed
38.
Beguin P, Nagashima K, Nishimura M, Gonoi T, Seino S (1999) PKA-mediated phosphorylation of the human K(ATP) channel: separate roles of Kir6.2 and SUR1 subunit phosphorylation. EMBO J 18:4722–4732CrossRefPubMed
39.
Rajan AS, Hill RS, Boyd III AE (1989) Effect of rise in cAMP levels on Ca2+influx through voltage-dependent Ca2+ channels in HIT cells. Second-messenger synarchy in β-cells. Diabetes 38:874–880PubMed
40.
Charles MA, Fanska R, Schmid FG, Forsham PH, Grodsky GM (1973) Adenosine 3′,5′-monophosphate in pancreatic islets: glucose-induced insulin release. Science 179:569–571PubMed
41.
Grill V, Cerasi E (1973) Activation by glucose of adenyl cyclase in pancreatic islets of the rat. FEBS Letters 33:311–314CrossRefPubMed
42.
Krupinski J, Cali JJ (1998) Molecular diversity of the adenylyl cyclases. Adv Second messenger Phosphoprotein Res 32:53–79PubMed
43.
Wayman GA, Impey S, Wu Z, Kindsvogel W, Prichard L, Storm DR (1994) Synergistic activation of the type I adenylyl cyclase by Ca2+ and Gs-coupled receptors in vivo. J Biol Chem 269:25400–25405PubMed
44.
Wu Z-L, Thomas SA, Villacres EC et al. (1995) Altered behavior and long-term potentiation in type I adenylyl cyclase mutant mice. Proc Natl Acad Sci USA 92:220–224PubMed
45.
Storm DR, Hansel C, Hacker B, Parent A, Linden DJ (1998) Impaired cerebellar long-term potentiation in type I adenylyl cyclase mutant mice. Neuron 20:1199–1210PubMed
46.
Schaefer ML, Wong ST, Wozniak DF et al. (2000) Altered stress-induced anxiety in adenylyl cyclase type VIII-deficient mice. J Neurosci 20:4809–4820PubMed
47.
Valverde I, Vandermeers A, Anjaneyulu R, Malaisse WJ (1979) Calmodulin activation of adenylate cyclase in pancreatic islets. Science 206:225–227
48.
Sharp GWG, Wiedenkeller DE, Kaelin D, Siegel EG, Wollheim CB (1980) Stimulation of adenylyl cyclase by Ca2+ and calmodulin in rat islets of Langerhans: explanation for the glucose-induced increase in cyclic AMP levels. Diabetes 29:74–77
49.
Gromada J, Bokvist K, Ding WG, Holst JJ, Nielsen JH, Rorsman P (1998) Glucagon-like peptide 1 (7–36) amide stimulates exocytosis in human pancreatic beta-cells by both proximal and distal regulatory steps in stimulus-secretion coupling. Diabetes 47:57–65PubMed
50.
Kanno T, Suga S, Wu J, Kimura M, Wakui M (1998) Intracellular cAMP potentiates voltage-dependent activation of L-type Ca2+ channels in rat islet beta-cells. Pflugers Arch 435:578–580CrossRefPubMed
51.
Ämmälä C, Ashcroft FM, Rorsman P (1993) Calcium-independent potentiation of insulin release by cyclic AMP in single β-cells. Nature 363:356–358PubMed
52.
Britsch S, Krippeit-Drews P, Lang F, Gregor M, Drews G (1995) Glucagon-like peptide-1 modulates Ca2+ current but not K+ATP current in intact mouse pancreatic B-cells. Biochem Biophys Res Commun 207:33–39CrossRefPubMed
53.
Fagan KA, Graft RA, Tolman S, Schaack J, Cooper DMF (2000) Regulation of a Ca2+-sensitive adenylyl cyclase in an excitable cell. Role of voltage-gated versus capacitative Ca2+ entry. J Biol Chem 275:40187–40194CrossRefPubMed
54.
Abdel-Halim SM, Guenifi A, He B et al. (1998) Mutations in the promotor of adenylyl cyclase (AC)-III gene, overexpression of AC-III mRNA, and enhanced cAMP generation in islets from the spontaneosly diabetic GK rat model of type 2 diabates. Diabetes 47:498–504PubMed
55.
Leech CA, Castonguay MA, Habener JF (1999) Expression of adenylyl cyclase subtypes in pancreatic β-cells. Biochem Biophys Res Comm 254:703–706CrossRefPubMed
56.
Choi E-J, Xia Z, Storm DR (1992) Stimulation of the type III olfactory adenylyl cyclase by calcium and calmodulin. Biochemistry 31:6492–6498PubMed
57.
Wayman GA, Impey S, Storm DR (1995) Ca2+- inhibition of type III adenylyl cyclase in vivo. J Biol Chem 270:21480–21486CrossRefPubMed
58.
Portha B, Serradas P, Bailbé D, Suzuki K-I, Goto Y, Giroix M-H (1991) β-cell insensitivity to glucose in the GK rat, a spontaneous nonobese model for type II diabetes. Diabetes 40:486–491PubMed
59.
Abdel-Halim SM, Guenifi A, Khan A et al. (1996) Impaired coupling of glucose signal to the exocytotic machinery in diabetic GK rats. Diabetes 45:934–940PubMed
60.
Guenifi A, Portela-Gomes GM, Grimelius L, Efendic S, Abdel-Halim SM (2000) Adenylyl cyclase isoform expression in non-diabetic and diabetic Goto-Kakizaki (GK) rat pancreas. Evidence for distinct overexpression of type-8 adenylyl cyclase in diabetic GK rat islets. Histochem Cell Biol 113:81–89CrossRefPubMed
61.
Cerasi E, Luft R (1970) Diabetes mellitus-A disorder of cellular information transmission? Horm Metab Res 2:246–249PubMed
62.
Chiono M, Mahey R, Tate G, Cooper DMF (1995) Capacitative Ca2+ entry exclusively inhibits cAMP synthesis in C6-2B glioma cells. J Biol Chem 270:1149–1155CrossRefPubMed
63.
Fagan KA, Mahey R, Cooper DMF (1996) Functional co-localization of transfected Ca2+-stimulable adenylyl cyclases with capacitative Ca2+ entry sites. J Biol Chem 271:12438–12444CrossRefPubMed
64.
Gao T, Puri TS, Gerhardstein BL, Chien AJ, Green RD, Hosey MM (1997) Identification and subcellular localization of the subunits of L-type calcium channels and adenylyl cyclase in cardiac myocytes. J Biol Chem 272:19401–19407CrossRefPubMed
65.
Watson EL, Jacobson KL, Singh JC et al. (2000) The type 8 adenylyl cyclase is critical for Ca2+ stimulation of cAMP accumulation in mouse parotid acini. J Biol Chem 275:14691–14699CrossRefPubMed
66.
Steinberg SF, Brunton LL (2001) Compartmentation of G protein-coupled signaling pathways in cardiac myocytes. Annu Rev Pharmacol Toxicol 41:751–773CrossRefPubMed
67.
Zaccolo M, Pozzan T (2002) Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes. Science 295:1711–1715CrossRefPubMed
68.
Sato Y, Nenquin M, Henquin JC (1998) Relative contribution of Ca2+-dependent and Ca2+-independent mechanisms to the regulation of insulin secretion by glucose. FEBS Lett 421:115–119CrossRefPubMed
Metadata
Title
Type VIII adenylyl cyclase in rat beta cells: coincidence signal detector/generator for glucose and GLP-1
Authors
D. Delmeire
D. Flamez
S. A. Hinke
J. J. Cali
D. Pipeleers
F. Schuit
Publication date
01-10-2003
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 10/2003
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-003-1203-8

Other articles of this Issue 10/2003

Diabetologia 10/2003 Go to the issue

Short Communication

The prevalence of insulin autoantibodies at the onset of Type 1 diabetes is higher in males than females during adolescence

EASD

EASD News Section October 2003

Article

Leptin as an adjunct of insulin therapy in insulin-deficient diabetes

Article

Autoantigen-specific protection of non-obese diabetic mice from cyclophosphamide-accelerated diabetes by vaccination with dendritic cells

Article

Saturated-fat diet induces moderate diabetes and severe glomerulosclerosis in hamsters

Article

A high carbohydrate diet does not induce hyperglycaemia in a mitochondrial glycerol-3-phosphate dehydrogenase-deficient mouse
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits